Modafinil alternatives (not necessarily eugeroic)
modafinil alternatives cognitive enhancement wakefulness 2025
| Compound | Class | Mechanism | Notes |
|---|---|---|---|
| Armodafinil (Nuvigil) | Eugeroic | R-enantiomer of modafinil; same MOA | Longer peak, slightly cleaner than modafinil; half the dose needed |
| Solriamfetol (Sunosi) | Dopamine/NE reuptake inhibitor | Dual DAT/NET inhibitor | FDA-approved for narcolepsy/OSA; stronger stimulant profile than modafinil |
| Pitolisant (Wakix) | H3 antagonist/inverse agonist | Increases histamine, DA, NE in brain | Non-scheduled; unique MOA; no abuse potential |
| Methylphenidate (Ritalin) | NDRI | Blocks DAT and NET | Strong executive function boost; higher abuse liability; shorter-acting |
| Amphetamine salts (Adderall) | NDRA + releaser | Reverses DAT/NET, releases monoamines | Most potent; significant abuse/cardiovascular risk |
| Lisdexamfetamine (Vyvanse) | Amphetamine prodrug | Converted to d-amphetamine in body | Smoother, longer onset; lower abuse potential than Adderall |
| Atomoxetine (Strattera) | Selective NRI | Pure NET inhibitor | Non-stimulant; weeks to work; better for ADHD than acute wakefulness |
| Bupropion (Wellbutrin) | NDRI | Weak DAT/NET reuptake inhibitor | Mild stimulant effect; often used off-label; antidepressant |
| Compound | Notes |
|---|---|
| Tasimelteon | Melatonin receptor agonist - circadian rhythm disorders, not wakefulness per se |
| Flmodafinil (CRL-40,940) | Modafinil derivative; more potent, bis-fluoro substitution; research chemical in most jurisdictions |
| Adrafinil | Prodrug of modafinil; OTC in some countries; liver stress with long-term use |
| CE-123 | Modafinil analogue filed in Red Bull patent (2018/2019); not commercially available |
| Compound | Mechanism | Evidence Level |
|---|---|---|
| Caffeine + L-Theanine | Adenosine antagonism + GABA modulation | Strong; best-studied OTC combo; smooths caffeine jitters |
| Citicoline (CDP-Choline) | Choline precursor; boosts acetylcholine + phosphatidylcholine | Moderate; attention and memory benefits in human trials |
| Alpha-GPC | Another choline precursor | Similar to citicoline; popular in nootropic stacks |
| Bacopa Monnieri | Adaptogen; serotonin/acetylcholine modulation | Decent RCT data for memory, but takes 8-12 weeks |
| Lion's Mane mushroom | NGF stimulation (hericenones/erinacines) | Promising; mostly animal data, some human trials for cognition |
| Rhodiola Rosea | MAOI-like; reduces mental fatigue | Good evidence for fatigue/burnout; weaker for raw stimulation |
| Panax Ginseng | Multiple; nitric oxide, GABA modulation | Some RCT support for mental performance and fatigue |
| Racetams (Piracetam, Aniracetam, Pramiracetam) | AMPA receptor modulation; acetylcholine | Mixed evidence; widely used; grey-area legal status varies by country |